Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2014

Aug 5, 2014

284_dirs_2014-08-05_23786fd3-67d5-4aff-9858-a9fd31f8653f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2014-08-04

Reporting Person: AMBROSE ADELE D (Sr.V-P & Chief Comuns Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-08-04 Common Stock M 15000.0000 $45.9800 Acquired 34443.9080 Direct
2014-08-04 Common Stock M 8400.0000 $44.3000 Acquired 42843.9080 Direct
2014-08-04 Common Stock S 28669.0000 $56.6368 Disposed 14174.9080 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-08-04 Stock Option (right to buy) $45.9800 M 15000.0000 Disposed 2018-01-31 Common Stock (15000.0000) Direct
2014-08-04 Stock Option (right to buy) $44.3000 M 8400.0000 Disposed 2018-02-28 Common Stock (8400.0000) Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.5800 to $56.7100, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.

F2: Holdings include shares acquired in dividend reinvestment transactions.

F3: The option became exercisable in equal installments on 2/1/2009, 2/1/2010 and 2/1/2011.

F4: The option became exercisable in equal installments on 2/28/2009, 2/28/2010 and 2/28/2011.